Related Experiment Video
Updated: Nov 5, 2025

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
Published on: May 10, 2024
[Research progress on bidirectional effect of microRNA on Alzheimer's disease and intervention with traditional
Li-Li Gu1, Qin Li1, Ning-Zi Wu1
1Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou Medical College Hangzhou 310013, China.
Abstract:
Alzheimer's disease(AD) is a chronic progressive neurodegenerative disease with recent memory impairment as the main clinical manifestation and senile plaques and neurofibrillary tangles as the main pathological changes. In recent years, the effect of microRNAs on AD has attracted widespread attention. Patients with AD have abnormal expression of miRNA, which is closed related to regulation of AD pathophysiology-related genes. Therefore, this paper first elaborated neuroprotective and toxic effects of microRNA in AD, and then explored relevant traditional Chinese medicines that can regulate miRNA in the treatment of AD, so as to provide basis for revealing the pathogenesis relationship between miRNA and AD and provide ideas for further development of anti-AD traditional Chinese medicine.
Insights
MicroRNAs (miRNAs) show altered expression in Alzheimer's disease (AD), impacting disease pathology. This study reviews miRNA's dual role in AD and traditional Chinese medicines that modulate miRNAs for potential AD treatments.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss, amyloid plaques, and neurofibrillary tangles.
- MicroRNAs (miRNAs) are small non-coding RNAs increasingly recognized for their role in regulating gene expression relevant to AD pathophysiology.
- Abnormal miRNA expression is a hallmark of AD, suggesting their involvement in disease development and progression.
Purpose of the Study:
- To elucidate the neuroprotective and neurotoxic effects of miRNAs in the context of Alzheimer's disease.
- To investigate traditional Chinese medicines (TCMs) capable of modulating miRNA expression for AD treatment.
- To establish a foundation for understanding the miRNA-AD pathogenesis relationship and guide the development of novel TCM-based anti-AD therapies.
Main Methods:
- Literature review of studies on miRNA function in Alzheimer's disease.
- Analysis of research on traditional Chinese medicines targeting miRNA pathways in AD.
- Synthesis of findings to connect miRNA dysregulation, AD pathology, and TCM interventions.
Main Results:
- MicroRNAs exhibit both beneficial and detrimental effects on neuronal function and survival in AD models.
- Specific miRNAs are dysregulated in AD patients, correlating with disease-related gene expression.
- Several TCMs demonstrate the ability to modulate aberrant miRNA levels implicated in AD.
Conclusions:
- MicroRNAs are critical players in Alzheimer's disease pathogenesis, offering potential therapeutic targets.
- Traditional Chinese medicines hold promise for regulating miRNA expression and mitigating AD progression.
- Further research into miRNA-TCM interactions can lead to innovative strategies for Alzheimer's disease treatment.
More Related Videos
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
Related Concept Videos
Alzheimer's Disease: Treatment
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
MicroRNAs
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...